Download Files:
Evolocumab
$480 – $1,950
Products Details
Product Description
– Evolocumab (AMG 145) is a human monoclonal antibody that inhibits PCSK9. Evolocumab binds to the circulating PCSK9 protein, inhibiting it from binding to the LDLR. Evolocumab can be used for the research of hypercholesterolemia and atherosclerotic cardiovascular diseases[1].
Web ID
– HY-P9930
Storage Temperature
– Store at 4°C for 2 years, protect from light
Shipping
– Blue Ice
Applications
– Metabolism-protein/nucleotide metabolism
Molecular Formula
– N/A
References
– [1]Fala L, et, al. Repatha (Evolocumab): Second PCSK9 Inhibitor Approved by the FDA for Patients with Familial Hypercholesterolemia. Am Health Drug Benefits. 2016 Mar;9(Spec Feature):136-9.
CAS Number
– 1256937-27-5
Molecular Weight
– N/A
Compound Purity
– 95.0
SMILES
– [Evolocumab]
Clinical Information
– Launched
Research Area
– Metabolic Disease; Cancer
Solubility
– H2O
Target
– Ser/Thr Protease
Pathway
– Metabolic Enzyme/Protease
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
